8
Oct
2024
![](/46/exhibition/00/05/02/cphi-milan.webp)
Liaoning Huarui Union Pharmaceutical Co., Ltd
Exhibitor at CPHI Milan 2024 stand 10C63, Finished Dosage Formulations
About Us
Categories
![Liaoning Huarui Union Pharmaceutical Co., Ltd](/Liaoning%20Huarui-comp322445.png)
-
CN
-
2024On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 10C63, Finished Dosage Formulations
Products Featured at CPHI Milan 2024
-
Product Benzoic acid & Salicylic acid ointment
Compound Benzoic acid & Salicylic acid Ointment is a compound preparation of benzoic acid and salicylic acid, mixed in 2:1 ratio to make a ointment. Benzoic acid in this product has the effect of inhibiting fungi, but the anti-bacterial effect is weak; Salicylic acid has the effect of inhibiting fungi ... -
Product Ciprofloxacin Tablets
Ciproflooxacin exhibits potent bacterial action by interfering with enzyme DNA gyrase which is needed for the synthesis of bacterial DNA. The in vitro antimicrobial spectrum of Ciprofloxacin includes wide range of microorganisms including the most Gram-negative bacteria and Gram-positive bacteria. Most str... -
Product Cotrimoxazole for oral Suspension
Cotrimoxazole for oral suspension is a sulfanilamide antimicrobial drug, which is a combination of sulfamethoxazole (SMZ) and trimethoprim (TMP). It has good antibacterial effect on non-enzymatic Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonel... -
Product Omeprazole Capsules 20mg
Omeprazole is a proton-pump inhibitor, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid. This drug was the first clinical useful drug in its class. Om... -
Product Omeprazole Sodium Injection
Omeprazole Sodium Injection is an alternative treatment for the following conditions when oral therapy is not appropriate: duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome.Administration:
1. Intravenous drip.
2. Dissolve the contents of the bottle in 100ml 0.9% sodiu...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance